Bioxcel therapeutics to present at canaccord genuity 41st annual growth conference

New haven, conn., july 19, 2021 (globe newswire) -- bioxcel therapeutics, inc. ("bioxcel" or the "company") (nasdaq: btai), today announced that dr. vimal mehta, ph.d., founder and chief executive officer of bioxcel, will participate in the canaccord genuity 41st annual growth conference on thursday, august 12, 2021 at 9:30 a.m. eastern time.
BTAI Ratings Summary
BTAI Quant Ranking